Eckert & Ziegler Strahlen- und Medizintechnik AG

Share Issue/Capital Change • Feb 4, 2009

News Details

Corporate | 4 February 2009 15:16

Eckert & Ziegler: capital increase successfully concluded / clear oversubscription

ECKERT & ZIEGLER Strahlen- und Medizintechnik AG / Capital Increase

Release of a Corporate News, transmitted by DGAP - a company of EquityStory
AG.
The issuer / publisher is solely responsible for the content of this announcement.

---

Berlin, 4 February 2009 – The Berlin based Eckert & Ziegler Strahlen- und
Medizintechnik AG (ISIN DE0005659700) has successfully concluded its
capital increase for cash. The company has increased its capital stock by
19.3%. 628,633 shares were thereby placed at a subscription price of 5.00
EUR each. The subscription period for the shareholders ended on 3 February
2009. After registering and implementing the capital increase in the
commercial register the capital stock amounts to 3,878,633 EUR, divided
into 3,878,633 shares. After the completion of the securities prospectus
the new shares will be permitted to be traded on the Frankfurt Stock
Exchange (Prime Standard).

With the capital increase around 3.1 million EUR flow into the company that
will be used for the recently announced purchase of the Braunschweig
isotope specialists nuclitec GmbH. 'The clear oversubscription in excess of
50% underlines the great trust investors have in the company and our
business model', explained Dr Andreas Eckert, Chairman of the Board at
Eckert & Ziegler AG. The capital increase, was accompanied by BankM –
representation of biw Bank für Investments und Wertpapiere AG.

Eckert & Ziegler AG, which achieved a turnover of approx. 70 million EUR in
2008 with around 410 employees, is one of the world’s largest providers of
isotopic components for radiation therapy and nuclear medicine.

Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, D-13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, Fax -112
E-Mail: karolin.riehle@ezag.de, www.ezag.de

04.02.2009 Financial News transmitted by DGAP

Language: English
Issuer: ECKERT & ZIEGLER Strahlen- und Medizintechnik AG
Robert-Rössle-Str. 10
13125 Berlin
Deutschland
Phone: +49 (0)30 941 084-0
Fax: +49 (0)30 941 084-112
E-mail: karolin.riehle@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart;
Freiverkehr in Berlin, München, Hamburg, Düsseldorf

End of News DGAP News-Service

---